Zota Health Care Appoints Akshay Kumar as Brand Ambassador for UGO Generic
Zota Health Care Limited has appointed legendary actor and philanthropist, Mr. Akshay Kumar, as the brand ambassador for the Company and its generic medicine brand, UGO Generic. The collaboration aims to significantly advance Zota Health Care's national footprint and deepen consumer trust across India.Under the agreement, UGO Generic will be operated by M/s KMHP Ventures Limited, the Wholly Owned Subsidiary of Zota Health Care Limited. The brand focuses on providing high-quality generic medicines both B2B and B2C. Its pan India reach will be established through the company's owned stores and an ambitious network targeting approximately 12.5 lakhs retail pharmacies.
The association is intended to add immense strength and mass connect, supporting the company's vision of making affordable, high-quality generic medicines accessible to every home in India. The partnership is marked as a defining milestone for Zota Health Care, reinforcing its national presence.
Ketankumar Zota, Chairman of Zota Health Care Limited, commented on the operational development, stating, "We are delighted to welcome Mr. Akshay Kumar to the Zota family. His influence extends far beyond cinema, making him a widely respected figure admired for his discipline, reliability, and strong personal integrity. These qualities closely align with our mission of making healthcare affordable and accessible for all. With Mr. Akshay Kumar representing Zota and UGO Generic, we are confident of enhancing our brand presence and driving stronger growth, wider reach, and deeper impact across India."
About Zota Health Care Limited
Zota Health Care Ltd. (Zota), listed on the NSE, has been an active participant in the Indian healthcare sector since 2000. Headquartered in Surat, the company's operations are managed by a team of over 520 professionals.The company specializes in the development, manufacturing, and marketing of diverse product lines, including pharmaceutical, ayurvedic, nutraceutical, and over-the-counter products. Zota Health Care operates through three primary divisions: marketing, export, and its retail pharmacy chain.
Zota’s commitment to expanding accessibility was highlighted with the launch of Davaindia in 2017. This generic pharmacy chain is equipped with over 2,000 SKUs of quality medicines. The business model emphasizes backward and forward integration to ensure efficient management of the entire product life cycle. Furthermore, Zota maintains a reputation in the industry through its innovative Research and Development team, which consistently invests in pioneering healthcare solutions.
Zota Health Care’s core operational areas include:
| Division | Activity |
|---|---|
| Development, Manufacturing, Marketing | Pharmaceutical, Ayurvedic, Nutraceutical, and Over-the-Counter Products |
| Operations | Marketing, Export, and Retail Pharmacy Chain |
| Retail Presence | Davaindia (Launched in 2017) with over 2,000 SKUs |
ZOTA Stock Price Movement
On Tuesday, Zota Health Care Limited shares edged higher, closing at ₹1205.4 after gaining 0.09% for the session. The stock was supported by a significant trading volume of 21,095 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: